Premium
Clinical utility of fluorescence in situ hybridization‐based diagnosis of BCR‐ABL1 like ( P hiladelphia chromosome like) B ‐acute lymphoblastic leukemia
Author(s) -
Anagnostou Theodora,
Knudson Ryan A.,
Pearce Kathryn E.,
Meyer Reid G.,
Pitel Beth A.,
Peterson Jess F.,
Baughn Linda B.,
Reichard Kaaren K.,
Ketterling Rhett P.,
KloftNelson Sara M.,
Knutson Darlene L.,
Khan Shakila P.,
Gangat Naseema,
Litzow Mark R.,
Hogan William J.,
Wolanskyj Alexandra,
AlKali Aref,
Begna Kebede H.,
Elliott Michelle,
Pardanani Animesh,
Foran James,
Shah Mithun,
Tefferi Ayalew,
Alkhateeb Hassan,
Halling Kevin,
Rodriguez Vilmarie,
Greipp Patricia T.,
Patnaik Mrinal M.
Publication year - 2020
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25729
Subject(s) - fluorescence in situ hybridization , lymphoblastic leukemia , philadelphia chromosome , in situ , in situ hybridization , medicine , breakpoint cluster region , abl , cancer research , microbiology and biotechnology , leukemia , chromosome , chromosomal translocation , chemistry , biology , immunology , genetics , receptor , gene , gene expression , tyrosine kinase , organic chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom